Second in our podcast series showcasing young researchers from the Freemasons Foundation Centre for Men’s Health, we hear from Dr Luke Selth who heads up the prostate cancer research program in the Dame Roma Mitchell Cancer Research Laboratories, in the Faculty of Health and Medical Sciences, the University of Adelaide, and who is leading a war on the androgen receptor to combat prostate cancer.
What you will hear In this podcast “At wAR with the androgen receptor!”
- 2:59 – Dr Luke Selth summarises what is the androgen receptor (AR) and why is it important in prostate cancer
- 5:14 – We hear from Prof WayneTilley about the history of AR research and androgen deprivation therapy (ADT)
- 10:10 – Back to Luke: The similarities between prostate and breast cancer
- 10:56 – How is early stage prostate cancer treated
- 12:25 – We hear from Dr Michael O’Callaghan from the South Australian Prostate Cancer Registry (SA-PCCOC) about prostate cancer in South Australia
- 16:40 – Back to Luke: How effective is ADT for men with advanced prostate cancer?
- 18:55 – How close are we to a cure?
- 21:33 – What new treatments are Luke and his team working on currently?
- 23:17 – How best to contact Luke